Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

ARWRARWR

Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ARROWHEAD PHARMACEUTICALS IN

Yes. Charles Schwab Investment Management holds 923,927 shares of ARWR (Arrowhead Pharmaceuticals in), worth $75.3M, as of its Q2 2026 13F filing. It reduced the position by 268,158 shares (-22.5%) from Q1 2026. Charles Schwab Investment Management has held ARWR in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$75.3M

Current Shares

923,927

Total Value Change

+$55.8M

Total Shares Change

-83,008

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
923,927
-22.5%
$75.3M0.0%$81.51
0
2026-Q1
Decreased
1.2M
-11.9%
$74.7M0.0%$62.70
0
2025-Q4
Increased
1.4M
+0.6%
$89.9M0.0%$66.39
30
2025-Q3
Increased
1.3M
+15.0%
$46.4M0.0%$34.49
33
2025-Q2
Increased
1.2M
+13.1%
$18.5M0.0%$15.80
32
2025-Q1
Increased
1M
+1.7%
$13.2M0.0%$12.74
28
2024-Q4
Increased
1M
+1.1%
$19.1M0.0%$18.80
29
2024-Q3
Increased
1M
+1.3%
$19.5M0.0%$19.37
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used